Prolongation of primate cardiac allograft survival by treatment with ANTI-CD40 ligand (CD154) antibody.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Transplantation

• Publication date

  1999-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-199912150-00026PMID 10609959
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154.

  1999cited by this paper
• Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

  1999cited by this paper
• Pharmacokinetics/dynamics of 5c8, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeys.

  1998cited by this paper
• A new, biventricular working heterotopic heart transplant model: anatomic and physiologic considerations.

  1997cited by this paper
• CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.

  1997cited by this paper
• CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway.

  1996cited by this paper
• CD11b+CD28-CD4+ human T cells: activation requirements and association with HLA-DR alleles.

  1996cited by this paper
• Molecular and biological characterization of a murine ligand for CD40.

  1992cited by this paper
• CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation.

  1992cited by this paper
• Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help)

  1992cited by this paper
• Molecular and biological characterization of a murine ligand for CD40

  1992cited by this paper
• A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.

  1990cited by this paper

• CD40 Gene Variants and Disease Susceptibility: A Comprehensive Review of Associations with Immune-Mediated Inflammatory Diseases, Cancer, and Infectious Diseases

  2025cites this paper
• Leukocyte dynamics in Cynomolgus monkeys following heterotopic heart allotransplantation under costimulation pathway blockade

  2025cites this paper
• Enhanced Costimulation Blockade With αCD154, αCD2, and αCD28 to Promote Heart Allograft Tolerance in Nonhuman Primates

  2025cites this paper
• Tolerogenic Therapies in Cardiac Transplantation

  2025cites this paper
• Animal models for transplant immunology: bridging bench to bedside

  2024cites this paper
• TNX-1500, an Fc-modified Anti-CD154 Antibody, Prolongs Nonhuman Primate Cardiac Allograft Survival.

  2023cites this paper
• Novel Approaches to Immunomodulation for Solid Organ Transplantation.

  2023cites this paper
• Induction of donor-specific tolerance to heart transplantation: From concept to clinical translation.

  2022cites this paper
• CD40-CD40L Blockade: Update on Novel Investigational Therapeutics for Transplantation

  2022cites this paper
• Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation.

  2019cites this paper
• Pilot Study of Delayed ICOS / ICOS-L Blockade With alphaCD 40 to Modulate Pathogenic Alloimmunity in a Primate Cardiac Allograft Model

  2018cites this paper
• Selective CD28 Inhibition Modulates Alloimmunity and Cardiac Allograft Vasculopathy in Anti–CD154-Treated Monkeys

  2018cites this paper
• Development of transplant immunosuppressive agents – considerations in the use of animal models

  2018cites this paper
• Pilot Study of Delayed ICOS/ICOS-L Blockade With αCD40 to Modulate Pathogenic Alloimmunity in a Primate Cardiac Allograft Model

  2018cites this paper
• Comparative Evaluation of &agr;CD40 (2C10R4) and &agr;CD154 (5C8H1 and IDEC-131) in a Nonhuman Primate Cardiac Allotransplant Model

  2017cites this paper
• Animal Models of Transplantation

  2016cites this paper
• The utility of animal models in developing immunosuppressive agents.

  2015cites this paper
• Update on CD40 and CD154 blockade in transplant models.

  2015cites this paper
• Large Animal Models of Transplantation

  2014cites this paper
• Current Pathways for Immune Manipulation

  2014cites this paper
• Lack of association between CD40 polymorphisms and acute rejection in German liver transplant recipients.

  2014cites this paper
• Primate models in organ transplantation.

  2013cites this paper
• Co-Stimulatory Blockade and Tolerance Induction in Transplantation

  2012cites this paper
• Inducing CTLA-4–Dependent Immune Regulation by Selective CD28 Blockade Promotes Regulatory T Cells in Organ Transplantation

  2010cites this paper
• Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges.

  2009cites this paper
• Chapter 2 Prevention of kidney allograft rejection using anti-CD 40 and anti-CD 86 in primates

  2008cites this paper
• Non-human primate models in allo-transplantation research: A short review

  2008cites this paper
• Anti-CD40L monoclonal antibody treatment induces long-term, tissue-specific, immunologic hyporesponsiveness to peripheral nerve allografts.

  2008cites this paper
• AP-1 and STAT-1 decoy oligodeoxynucleotides attenuate transplant vasculopathy in rat cardiac allografts.

  2008cites this paper
• Anti-CD40L Monoclonal Antibody Treatment Induces Long-Term, Tissue-Specific, Immunologic Hyporesponsiveness to Peripheral Nerve Allografts

  2008cites this paper
• CCR5 Blockade Modulates Inflammation and Alloimmunity in Primates1

  2007cites this paper
• The importance of large animal models in transplantation.

  2007cites this paper
• CD154 Blockade, Sirolimus, and Donor-Specific Transfusion Prevents Renal Allograft Rejection in Cynomolgus Monkeys Despite Homeostatic T-Cell Activation

  2007cites this paper
• CCR 5 Blockade Modulates Inflammation and Alloimmunity in Primates 1

  2007cites this paper
• Regulatory Dendritic Cells and Their Potential for Tolerance Induction

  2007cites this paper
• Progress toward antibody-induced transplantation tolerance.

  2007cites this paper
• Tolerance in heart transplantation: the Holy Grail, or an attainable goal?

  2007cites this paper
• Short-Term Anti-CD40 Ligand Costimulatory Blockade Induces Tolerance to Peripheral Nerve Allografts, Resulting in Improved Skeletal Muscle Function

  2006cites this paper
• Immunosuppression for heart transplantation: where are we now?

  2006cites this paper
• Alloimmunity in Primate Heart Recipients with CD154 Blockade: Evidence for Alternative Costimulation Mechanisms

  2006influential citation
• New approaches to prevent transplant rejection: Co-stimulation blockers anti-CD40L and CTLA4Ig

  2006cites this paper
• Experimental models of graft arteriosclerosis.

  2006cites this paper
• Induction of transplantation tolerance in non-human primate preclinical models

  2005cites this paper
• Kinetics of costimulatory molecule expression by T cells and dendritic cells during the induction of tolerance versus immunity in vivo

  2005cites this paper
• Humoral Immunity to Vimentin Is Associated with Cardiac Allograft Injury in Nonhuman Primates

  2005cites this paper
• Strategies for Tolerance Induction in Nonhuman Primates

  2005cites this paper
• IDEC‐131 (Anti‐CD154), Sirolimus and Donor‐Specific Transfusion Facilitate Operational Tolerance in Non‐Human Primates

  2005cites this paper
• Dimeric but not Monomeric Soluble CD40 Prolongs Allograft Survival and Generates Regulatory T Cells that Inhibit CTL Function

  2005cites this paper
• Quantitative mRNA expression analysis of co‐stimulatory molecules in sequential biopsies from heart allografts

  2005cites this paper
• Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation1

  2004cites this paper
• Immunosuppression and transplant immunology

  2004cites this paper
• Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model1

  2004cites this paper
• Preliminary in vivo pharmacokinetic and pharmacodynamic evaluation of a novel calcineurin-independent inhibitor of NFAT

  2004cites this paper
• Anti-CD40 Ligand Antibody Permits Regeneration through Peripheral Nerve Allografts in a Nonhuman Primate Model

  2004cites this paper
• Tolerance induction in clinical transplantation.

  2004cites this paper
• Anti-CD40 Ligand Antibody Permits Regeneration through Peripheral Nerve Allografts in a Nonhuman Primate Model

  2004cites this paper
• Preliminary in vivo pharmacokinetic and pharmacodynamic evaluation of a novel calcineurin‐independent inhibitor of NFAT

  2004cites this paper
• Reduced CD40L Expression on ex vivo Activated CD4+ T-Lymphocytes from Patients with Excellent Renal Allograft Function Measured with a Rapid Whole Blood Flow Cytometry Procedure

  2004cites this paper
• Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells.

  2003cites this paper
• Model of Skin Allotransplantation Antibody IDEC-131 in a Nonhuman Primate Rapamycin , and the CD 154-Specific Donor-Specific Blood Transfusion , Studies Investigating Pretransplant

  2003cites this paper
• Studies Investigating Pretransplant Donor-Specific Blood Transfusion, Rapamycin, and the CD154-Specific Antibody IDEC-131 in a Nonhuman Primate Model of Skin Allotransplantation1

  2003cites this paper
• Mycophenolic acid is a potent inhibitor of the expression of tumour necrosis factor‐ and tumour necrosis factor‐receptor superfamily costimulatory molecules

  2003cites this paper
• Intragraft gene and protein expression in rat liver allografts treated with costimulatory blockade alone or in combination with CyA.

  2003cites this paper
• Identification and Simian Immunodeficiency Virus Infection of CD1d-Restricted Macaque Natural Killer T Cells

  2003cites this paper
• CD154 Regulates Primate Humoral Immunity to Influenza

  2003cites this paper
• Crossing the bridge: large animal models in translational transplantation research

  2003cites this paper
• Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates

  2003cites this paper
• Effect of semi-invasive cardiovascular monitoring on the perioperative outcome of kidney or lung xenotransplantation in cynomolgus monkeys

  2003cites this paper
• T-Cell Costimulatory Pathways Relevant to Transplant Rejection and Tolerance

  2002cites this paper
• Context-based therapy: A conceptual framework for transplantation tolerance

  2002cites this paper
• Functional genomics of immune responses

  2002cites this paper
• Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions.

  2002cites this paper
• Induction of donor-specific tolerance by adenovirus-mediated cd40ig gene therapy in rat liver transplantation1

  2002cites this paper
• Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation

  2002cites this paper
• CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation

  2002cites this paper
• Recommendations of the National Heart, Lung and Blood Institute Heart and Lung Tolerance Working Group.

  2001cites this paper
• The role of CD154 in organ transplant rejection and acceptance.

  2001cites this paper
• Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.

  2001cites this paper
• Preclinical evaluation of tolerance induction protocols and islet transplantation in non‐human primates

  2001cites this paper
• Expression and Function of CD40 on Hematopoietic and Non-Hematopoietic Cells

  2001cites this paper
• Novel CD40-IgG adenovirus-mediated gene therapy as a potent immunosuppressive treatment for liver transplantation in rats.

  2001cites this paper
• Gene therapy for hepatocellular carcinoma—teaching old dogs new tricks

  2001cites this paper
• Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients.

  2001cites this paper
• CD40-ligand in primate cardiac allograft and viral immunity

  2001cites this paper
• Dependence of murine obstructive airway disease on CD40 ligand.

  2001cites this paper
• Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.

  2001cites this paper
• Cd40 Ligand (Cd154) Triggers a Short-Term Cd4+ T Cell Activation Response That Results in Secretion of Immunomodulatory Cytokines and Apoptosis

  2000cites this paper
• Considerations for Novel Therapies in the Future

  2000cites this paper
• Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction.

  2000cites this paper
• Immune regulation by CD40-CD40-l interactions - 2; Y2K update.

  2000cites this paper
• Immune regulation by CD40-CD40-l interactions - 2; Y2K update.

  2000cites this paper